References
- Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996; 275: 1571–1576.
- Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009; 27: 2121–2158.
- Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009; 361: 2153–2164.
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: 1665–1683.
- Reboldi G, Angeli F, Cavallini C, et al. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens. 2008; 36: 1282–1289.
- Chobanian AV. Does it matter how hypertension is controlled? N Engl J Med. 2008; 359: 2485–2488.
- Turnbull F, Neal B, Ninomiya T, et al. Effects of different regiments to lower blood pressure on major cardiovascular events in older and young adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121–1123.
- Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25: 1105–1187.
- Mancia G, Zancehtti A, European Society of Hypertension-European Society of Cardiology. Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage. J Hypertens. 2008; 26: 164–168.
- Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European Guidelines on hypertension management: European Society of Hypertension Task Force document. J Hypertens. 2009; 27: 2121–2158.